Streetbeat News

Price Targets

ZION

Truist Securities analyst Jennifer Demba downgraded Zions Bancorp (NASDAQ:ZION) from Buy to Hold and set a price target of $46.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:40 pm

CRC

B of A Securities analyst Kalei Akamine has downgraded California Resources (NYSE:CRC) from Buy to Neutral and reduced the price target from $64 to $60.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:33 pm

EOG

B of A Securities analyst Doug Leggate downgraded EOG Resources (NYSE:EOG) from Buy to Neutral and reduced the price target from $147 to $140.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:31 pm

NOG

B of A Securities analyst John Abbott has downgraded Northern Oil & Gas (NYSE:NOG) from Buy to Underperform and set a price target of $39.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:30 pm

GPOR

B of A Securities analyst Doug Leggate downgraded Gulfport Energy (NYSE:GPOR) from Buy to Neutral and set a price target of $151.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:28 pm

HII

Barclays analyst David Strauss has downgraded Huntington Ingalls Industries (HII) from Overweight to Equal-Weight while increasing the price target from $250 to $280. The adjustment reflects a more neutral stance on the stock, albeit with a higher expected price level.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:27 pm

EXAI

B of A Securities analyst Michael Ryskin has downgraded Exscientia (NASDAQ:EXAI) from Buy to Neutral and reduced the price target from $11 to $9.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:15 pm

ERAS

B of A Securities analyst Alec Stranahan has downgraded Erasca (NASDAQ:ERAS) from Buy to Neutral and reduced the price target from $11 to $6.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:13 pm

CHDN

Wells Fargo analyst Daniel Politzer has downgraded Churchill Downs (NASDAQ:CHDN) from Overweight to Equal-Weight and set a price target of $137.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:11 pm

GIL

UBS analyst Jay Sole has downgraded Gildan Activewear (NYSE:GIL) from Buy to Neutral and reduced the price target from $40 to $37, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 2:09 pm